Sequoia Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $925K | Buy |
1,761
+146
| +9% | +$76.7K | 0.01% | 706 |
|
|
2025
Q1 | $1.02M | Sell |
1,615
-134
| -8% | -$85K | 0.01% | 605 |
|
|
2024
Q4 | $1.25M | Buy |
1,749
+9
| +0.5% | +$6.41K | 0.01% | 515 |
|
|
2024
Q3 | $1.83M | Buy |
1,740
+218
| +14% | +$229K | 0.02% | 395 |
|
|
2024
Q2 | $1.6M | Buy |
1,522
+73
| +5% | +$76.7K | 0.02% | 376 |
|
|
2024
Q1 | $1.39M | Sell |
1,449
-650
| -31% | -$626K | 0.02% | 398 |
|
|
2023
Q4 | $1.84M | Buy |
2,099
+900
| +75% | +$791K | 0.02% | 368 |
|
|
2023
Q3 | $987K | Sell |
1,199
-1
| -0.1% | -$823 | 0.02% | 338 |
|
|
2023
Q2 | $862K | Sell |
1,200
-26
| -2% | -$18.7K | 0.01% | 375 |
|
|
2023
Q1 | $1.01M | Buy |
1,226
+174
| +17% | +$143K | 0.02% | 313 |
|
|
2022
Q4 | $759K | Buy |
1,052
+668
| +174% | +$482K | 0.02% | 346 |
|
|
2022
Q3 | $265K | Sell |
384
-94
| -20% | -$64.9K | 0.01% | 425 |
|
|
2022
Q2 | $283K | Sell |
478
-17
| -3% | -$10.1K | 0.01% | 454 |
|
|
2022
Q1 | $346K | Buy |
495
+93
| +23% | +$65K | 0.01% | 450 |
|
|
2021
Q4 | $254K | Buy |
+402
| New | +$254K | 0.01% | 485 |
|
|
2021
Q1 | – | Sell |
-420
| Closed | -$203K | – | 459 |
|
|
2020
Q4 | $203K | Sell |
420
-37
| -8% | -$17.9K | 0.01% | 398 |
|
|
2020
Q3 | $256K | Sell |
457
-100
| -18% | -$56K | 0.01% | 325 |
|
|
2020
Q2 | $347K | Buy |
557
+38
| +7% | +$23.7K | 0.02% | 271 |
|
|
2020
Q1 | $253K | Buy |
+519
| New | +$253K | 0.02% | 292 |
|
|
2017
Q4 | – | Sell |
-559
| Closed | -$250K | – | 319 |
|
|
2017
Q3 | $250K | Sell |
559
-153
| -21% | -$68.4K | 0.03% | 236 |
|
|
2017
Q2 | $350K | Buy |
712
+12
| +2% | +$5.9K | 0.04% | 188 |
|
|
2017
Q1 | $271K | Hold |
700
| – | – | 0.03% | 218 |
|
|
2016
Q4 | $257K | Buy |
+700
| New | +$257K | 0.04% | 225 |
|
|
2016
Q1 | – | Sell |
-546
| Closed | -$296K | – | 214 |
|
|
2015
Q4 | $296K | Buy |
546
+19
| +4% | +$10.3K | 0.12% | 129 |
|
|
2015
Q3 | $245K | Buy |
527
+10
| +2% | +$4.65K | 0.11% | 140 |
|
|
2015
Q2 | $264K | Buy |
+517
| New | +$264K | 0.11% | 150 |
|